Metraipolis › archive › dc_cb2931cc8f57
Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41848906
- DOI
- 10.1007/s10741-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T06:54:34.087Z
- SHA-256 of the archived text
ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113- Stable URL of this page
https://metraipolis.com/documento/dc_cb2931cc8f57
How to cite
Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906 — Europe PMC (en), https://europepmc.org/article/MED/41848906 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cb2931cc8f57 (Metraipolis archive dc_cb2931cc8f57, sha256 ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113)
BibTeX
@misc{dccb2931cc8f57,
title = {Evolving strategies in obstructive hypertrophic cardiomyopathy: myosin inhibitors as monotherapy compared with beta-blockers — Europe PMC PMID:41848906},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41848906},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cb2931cc8f57; sha256 ffb71d6d8de55e58fead2b3243ca7be22c565e6b62ab5bae40abf27a71db1113},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41848906. Agents can read the archived copy with the MCP tool read_document.